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Abstract
Background: Use of treponemal tests to screen for syphilis (caused by Treponema pallidum pallidum) poses
challenges with infection status classification, especially in settings where other treponemal infections are endemic.
This study aimed to determine the validity of the syphilis surveillance testing strategy implemented since 2004
using two treponemal tests, and estimate the seroprevalence of active syphilis infection in Ghana where yaws
(caused by Treponema pallidum pertenue) is endemic.
Methods: We retested sera from the 2007 HIV sentinel survey (HSS) using a traditional algorithm, quantitative rapid
plasma reagin test followed by qualitative Treponema pallidum haemagglutination assay. The adjusted
seroprevalence of active syphilis was calculated by applying the proportions of active syphilis within identified
categories of HSS samples during the retesting, to the entire population of HSS samples. The 95% confidence
intervals (CIs) were calculated for each proportion, and the t-test was used to assess differences in proportions.
Results: Of 2,214 samples that were retested, 203 (9.2%) had active syphilis infection, 21 (0.9%) were biological false
reactions, 640 (28.9%) were past or treated syphilis infections, and 1,350 (61%) were uninfected. The current syphilis
testing strategy overestimated the seroprevalence of active syphilis infection by a third (HSS versus traditional
algorithm: 6.0% (95% CI: 5.6–6.3) vs. 4.5% (95% CI: 4.2–4.8); p < 0.001), and had low positive predictive value (16.8%)
for detecting active syphilis infection. More than half (51.9%) of HSS syphilis positive cases were actually past/treated
treponemal infections, possibly previous exposure to yaws.
Conclusion: There is an urgent need to review the current syphilis sentinel surveillance testing strategy in Ghana in
the context of concurrent endemic treponematoses, to better inform policy.
Keywords: Syphilis surveillance, Syphilis seroprevalence, Treponemal tests, Non-treponemal tests, Yaws, HIV sentinel
survey, Ghana
Background
Surveillance of syphilis seroprevalence is a key compo-
nent of the World Health Organization’s (WHO) strat-
egy for the global elimination of congenital syphilis [1].
Syphilis seroprevalence surveillance among pregnant
women has been conducted as part of HIV sentinel sur-
vey (HSS) in many countries, including Ghana [2], and
is a proxy indicator for monitoring the prevalence of
sexually transmitted infections (STIs) in the general
population [2, 3]. Serological testing for syphilis involves
the detection of two types of antibodies, non-treponemal
and treponemal antibodies. Non-treponemal antibodies
become reactive during the inflammatory phase caused by
acute syphilis and non-reactive (serorevert) after success-
ful treatment or in long-standing/late stages of treponemal
infections, while the specific treponemal antibodies rise
during the acute phase and usually remain detectable for
life, even after successful treatment [3, 4]. Therefore,
traditionally, serologic testing for syphilis involves screen-
ing with a non-treponemal test such as rapid plasma re-
agin (RPR) to identify persons with possible untreated
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infections, followed by confirmation using a treponemal
test (e.g. Treponema pallidum haemagglutination assay
[TPHA]) [3, 4]. For purposes of high throughput testing,
some laboratories have adopted a reverse screening se-
quence; screening with an automated treponemal test first
followed by confirmation with a non-treponemal test [4].
This reverse algorithm still requires the use of a non-
treponemal test to identify active infections [4].
For reasons of performance and convenience, the HSS
resorted to the use of two treponemal tests for syphilis
sentinel surveillance testing in Ghana since 2004 [5].
The use of a treponemal test for syphilis (caused by
Treponema pallidum subspecies pallidum) screening
poses challenges with classification of infection status
[4], especially in settings where other treponemal infec-
tions including yaws (caused by Treponema pallidum
subspecies pertenue) are endemic [3]. The aims of this
study were (1) to determine the validity of the current
syphilis surveillance testing strategy in Ghana, which has
been implemented since 2004, in comparison to the
traditional WHO-recommended algorithm (i.e., RPR
followed by TPHA) as the gold standard [6]; and (2) to
estimate the seroprevalence of active maternal syphilis
by retesting archived sera from the 2007 HSS in the
context of endemic yaws. We hypothesized that syphilis
sentinel surveillance using two treponemal tests (Deter-
mine syphilis TP [DS] and TPHA tests) overestimates
the seroprevalence of active maternal syphilis in Ghana.
Methods
Study context and setting
Yaws and syphilis are the two treponemal infections of
public health importance in Ghana. Yaws is transmitted
by direct skin-to-skin contact mainly among children
under 15 years of age. Congenital infections do not occur,
possibly because active yaws is rare among women of
childbearing age [7]. Yaws has remained a public health
problem in Ghana over the past five decades, although the
prevalence varies between regions [8, 9]. Despite earlier
success of eradication campaigns with mass penicillin
treatment in the 1950s and 1960s [8], the disease still oc-
curs in all 10 regions of the country [9]. The highest inci-
dence has been reported in warm regions with high levels
of humidity and rainfall, especially the Eastern, Central,
Western, Ashanti and Volta regions, while the three
northern regions (Northern, Upper East and Upper West),
which are predominantly warm and dry, have the lowest
incidence rates in the country [9].
Syphilis is a global health problem but has not been a
major clinical problem in Ghana since the 1960s [1, 10].
While clinicians in STI clinics and general hospital set-
tings report attending to cases of the major STIs, they
hardly appear to see any cases of syphilis [10]. The very
low occurrence of clinically recognisable syphilis has
been attributed to the low prevalence of infection, which
resulted in part from the mass penicillin treatment cam-
paigns against yaws in the 1950s and 1960s [8, 10].
The national HSS has been conducted in 40 sites in-
volving over 18,000 antenatal attendees across the 10 re-
gions of the country since 2005. The HSS data has
reported highly variable “syphilis” seroprevalence rates
ranging from 0 to 33.9% [2], with a reported mean syphilis
seroprevalence of <0.5% (range 0–0.8%) prior to 2004 [1],
climbing to 6.6% in 2004, and ranging from 5.5 to 6.5%
thereafter [2, 5] after a change in the testing algorithm.
The HSS syphilis testing strategy departed from the trad-
itional WHO-recommended algorithm of screening with
RPR followed by TPHA confirmation [6], to the use of a
treponemal test (DS) for screening and maintaining the
“confirmatory” test as TPHA, thereby using two trepo-
nemal tests sequentially [2, 5, 11]. The switch of screening
test from RPR to DS was implemented for reasons of per-
formance (higher sensitivity) and practicality [5].
In 2003, the reported HSS regional “syphilis” sero-
prevalence rates were much lower than those of HIV
seroprevalence [11]. Since 2004, the Central, Eastern and
Western regions have had the highest regional “syphilis”
seroprevalence rates which are about 1.5 to 11 fold
higher than the corresponding HIV seroprevalence.
However, the three northern regions with the lowest
“syphilis” seroprevalence have rates similar to those of
HIV [2, 5]. Notably also, “syphilis” seroprevalence among
15–19 year olds have become much higher (1.5 to 6 fold
higher rates) than HIV since 2004, while the converse
was the case prior to 2004 [2, 5].
2007 HSS and selection of samples for retesting
The 2007 HSS involved 18,366 participants between the
ages of 15 and 49 years. Almost all (18,048, 98.3%) were
pregnant women attending antenatal services whilst the
remainder (318, 1.7%) were STI clinic attenders. All sam-
ples were initially tested at the various sentinel sites with
DS: DS-positive samples were further tested centrally at
the National Public Health and Reference Laboratory with
TPHA, whilst no further testing was done for DS-negative
samples. Of the 18,366 samples, 1,097 (6.0%) were positive
for both DS and TPHA and classified as “syphilis positive”
After the survey, all samples were stored at the National
Public Health and Reference Laboratory without any per-
sonal identifiers.
The list of all samples from the 2007 HSS was ob-
tained from the National AIDS/STI Control Programme
(NACP) for review and selection of samples for retest-
ing. The samples comprised of 1,294 (7.0%) DS-positive,
of which 1,097 (84.7%) were positive for TPHA, 135
(10.5%) negative for TPHA, and 62 (4.8%) whose TPHA
results were not available. Determine Syphilis TP results
for 31 TPHA-positive samples were also not available,
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and these samples were excluded from the subsequent
analysis to estimate the seroprevalence of active syphilis.
Sample selection for the retesting was weighted accord-
ing to the number of DS-positives in each site; for every
DS-positive sample the next consecutive DS-negative
sample (from the same site) was also selected. A total of
2,214 samples (12.1% of all HSS samples) were retrieved
for retesting, 1,096 DS-positive and 1,118 DS-negative
samples (Table 1).
Retesting of sera and interpretation of test results
Selected serum samples were transported on dry ice to the
Department of Clinical Microbiology, School of Medical
Sciences, Kwame Nkrumah University of Science and
Technology (KNUST) and Komfo Anokye Teaching
Hospital for retesting. All samples were retested using a
quantitative RPR test (Omega Diagnostics, Alva Scotland,
UK) and a qualitative TPHA test (Omega Diagnostics,
Alva Scotland, UK) according to the manufacturers’ rec-
ommendations. We did not have an independent trepo-
nemal assay to perform fluorescent treponemal antibody
absorption (FTA-ABS) test for the few RPR-positive/
TPHA-negative samples, as usually recommended [3, 12];
instead, these samples were retested with DS.
Samples which were positive by both RPR and TPHA
were classified as having “active syphilis”. These were
further classified as high titre active syphilis if the RPR
titre was ≥1:8, or low titre active syphilis if the RPR titre
was <1:8. Samples which were positive for RPR and
negative for TPHA were retested with DS and classified
as active syphilis if the DS was positive and biological
false reaction if DS was negative. Samples which were
negative for RPR and positive for TPHA were classified
as past or treated syphilis infection. Samples which were
negative for both RPR and TPHA were classified as
syphilis-uninfected [12].
Sample size estimation
A sample of 2000 DS tested samples (1000 positives and
1000 negatives) from the 2007 HSS was required to esti-
mate a positive predictive value (PPV) or negative predict-
ive value (NPV) of 20% (95% confidence interval [CI]:
17.6–22.6) and 90% (95% CI: 88.0–91.8), respectively.
Statistical analyses
The adjusted seroprevalence of active syphilis was cal-
culated by applying the seroprevalence of active syphilis
within four categories of HSS samples (DS+/TPHA+,
DS+/TPHA−, DS+/TPHA not available, and DS-/
TPHA not done; Fig. 1) that were identified during
retesting, to their respective categories in the entire
population of 18,366 HSS samples. The 95% CIs were
calculated for each proportion, and the t-test was
used to assess differences in proportions.
Results
The results of the selected HSS samples and the retesting
with RPR and TPHA are summarised in Fig. 1 and Table 2.
Of the 2,214 retested samples, 203 (9.2%; c1, c5 and c9
cells in Fig. 1) were positive by both RPR and TPHA (ac-
tive syphilis infection), 21 (0.9%; c2, c6 and c10 cells)
samples were RPR-positive and TPHA-negative (bio-
logical false reactions), 640 (28.9%; c3, c7 and c11 cells)
samples were RPR-negative and TPHA-positive (past or
treated syphilis infection), and 1,350 (61%; c4, c8 and
c12 cells) samples were negative by RPR and TPHA (un-
infected). When the 21 RPR+/TPHA- samples were
retested with DS, 10 were positive for DS and classified
as having active syphilis (c2 cell), while the remaining 11
were negative for DS and classified as biological false re-
actions (c6 cell). Determine Syphilis TP results for those
21 samples were the same as those initially obtained
during the HSS (see corresponding A cells for c2 and c6
cells). Overall, 213 samples were classified as having ac-
tive syphilis (Table 2), 145 (68.1%) had low titre (<1:8)
active syphilis, while the remaining 68 (31.9%) had high
titre (≥1:8) active syphilis (data not shown). About one
third (323/1001; c2 and c4 cells) of samples that were
TPHA-positive and half (30/59; cell c11) of samples that
were TPHA-negative during the HSS were found to have
the opposite result (i.e. being TPHA-negative and
TPHA-positive respectively), during retesting.
Results of the selected samples using HSS testing strat-
egy (two treponemal tests) and conventional testing
algorithm (RPR/TPHA) are compared in Fig. 1 and Table 3.
Of the 1,001 samples that were classified as cases of “active
syphilis infection” by the HSS testing strategy, only 168
(16.8%) (including the 10 RPR+/TPHA- samples which
were DS+, c2 cell) had active syphilis infection using the
traditional algorithm; actually, more than half (520 [51.9%],
c3 cell) of HSS active syphilis samples were cases of past or
treated syphilis or treponemal infections. Most samples
(995 [89%], c8 cell) classified as not having any syphilis in-
fection were also found to be negative for syphilis using
the conventional algorithm. However, 42 (3.8%, c5 cell) of
samples considered to be negative for syphilis during the
HSS were found to have active syphilis infection using the
conventional strategy. Three (8.3%) samples that were
Table 1 Ghana HIV Sentinel Survey (HSS) 2007 syphilis test
results of samples selected for syphilis serology retesting
Determine Syphilis
TP results
TPHA results
Positive Negative Not done Total
Positive 1,001 59 36 1,096
Negative 0 0 1,118 1,118
Total 1,001 59 1,154 2,214
TPHA Treponema pallidum haemagglutination assay
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positive for DS but had no available TPHA results from
the HSS were found to have active syphilis during retesting
(c9 cell). None of the DS-positive TPHA-negative samples
was positive for syphilis during retesting. Using data from
the 2007 HSS (Table 3), the seroprevalence of “active syph-
ilis” infection (1,097/18,366) was 6.0% (95% CI: 5.6–6.3).
Using data in Table 3 for seropositivity rate in each sub-
category of results for the HSS and applied to the category
distribution of the entire HSS panel (and excluding 31
samples for which DS results were not available) the
seroprevalence of active syphilis using the conventional
algorithm was estimated as (818.5/18,335) or 4.5% (95%
CI: 4.2–4.8). As expected, the use of two treponemal tests
significantly overestimated the seroprevalence of active
syphilis in Ghana by one-third compared to RPR/TPHA as
the gold standard algorithm (6.0% vs. 4.5%; p < 0.001).
Discussion
The seroprevalence of “active syphilis” in Ghana had in-
creased dramatically since 2005 when the NACP adopted
a strategy of using two sequential treponemal tests for
syphilis sentinel surveillance. Serological evidence from
retesting using the traditional algorithm and the know-
ledge of regional epidemiology of yaws in Ghana suggest
that the use of two treponemal tests may be overestimat-
ing the seroprevalence of active syphilis.
Most authorities recommend screening for syphilis with
a non-treponemal test and subsequent confirmation of
positive results with a specific treponemal test [3, 4, 6].
This traditional algorithm avoids problems with classifica-
tion of infection status when a reverse algorithm (screen-
ing with a treponemal test followed by a non-treponemal
test) or using two treponemal tests for the diagnosis of
Fig. 1 Serology results of selected samples from the 2007 HIV Sentinel Survey (HSS) and retesting with RPR and TPHA. DS-Determine syphilis TP;
TPHA- Treponema pallidum haemagglutination assay; TPHA0-TPHA result not available; RPR-rapid plasma reagin; Level A = HSS results of selected
samples; Levels B & C = Results of retesting with RPR, TPHA and DS
Table 2 Comparing results of HIV Sentinel Survey (HSS) and conventional syphilis testing strategies using selected archived sera
from 2007 HSS in Ghana
Results (and interpretation) of
RPR/TPHA retesting
Results of HSS testing strategy n (%)
DS+/TPHA+ DS−/TPHA− DS+/TPHA− DS+/TPHA0 Total
RPR+/TPHA+ (Active infection) 168 (16.8)a 42 (3.8) 0 (0) 3 (8.3) 213 (9.6)
RPR+/TPHA−(Biological false positive reaction) 0 (0)a 11 (1.0) 0 (0) 0 (0) 11 (0.5)
RPR−/TPHA+ (Past/treated infection) 520 (51.9) 70 (6.2) 30 (50.8) 20 (55.6) 640 (28.9)
RPR−/TPHA−(Uninfected) 313 (31.3) 995 (89.0) 29 (49.2) 13 (36.1) 1,350 (61.0)
Total 1,001 (100) 1,118 (100) 59 (100) 36 (100) 2,214 (100)
RPR rapid plasma reagin, TPHA Treponema pallidum haemagglutination assay, TPHA0− TPHA results not available, DS determine syphilis TP, aIncludes 10 RPR+/TPHA−
samples which were DS+; Excludes 10 RPR+/TPHA − samples which were DS+
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active syphilis is used [4]. The choice of a suitable testing
algorithm will also depend on the epidemiology of trepo-
nemal infections in the area. Yaws has been endemic in
Ghana over the past five decades [8, 9], while syphilis had
been relatively rare [10] until recent HSS data indicated
dramatic increases in “syphilis” (or more accurately,
“treponemal infection”) seroprevalence following a change
in the testing algorithm (from using RPR/TPHA to the
use of two treponemal tests) [1, 2, 5].
Not surprisingly, the current HSS testing strategy has
been overestimating the seroprevalence of active mater-
nal syphilis by a third since 2004. Less than one fifth of
samples identified as having “active syphilis infection” by
the HSS testing strategy were classified as “active syphilis
infection” by the traditional algorithm indicating that the
HSS strategy has a low PPV (16.8%) for detecting active
syphilis infection. As expected, over half of samples con-
sidered to have “active syphilis infection” by the HSS
strategy were classified as past or treated infections
using the traditional algorithm. Our results are in agree-
ment with those of a recent study conducted among 200
blood donors in Kumasi; using two treponemal tests (an
enzyme immunoassay and TPHA) the seroprevalence of
syphilis was reported to be 8% while the seroprevalence
of active syphilis (using RPR and either treponemal test)
was much lower, 3.5% [13]. Treponemal tests reactivity
persists over a lifetime. Therefore, reactive treponemal
tests alone are neither indicative of active infection nor
of the need for treatment but simply reflect the cumula-
tive incidence of treponemal infections over time [3, 4,
6, 14]. This is however a function of survival of infected
individuals, so seroprevalence may not consistently rise
with age. On the other hand, non-treponemal tests can
be non-reactive in the very early stages of syphilis infec-
tion and during late stages of the infection, and usually
serorevert (become non-reactive) after successful treat-
ment [4]. Therefore, samples which were classified as hav-
ing past or treated syphilis infection (RPR−/TPHA+)
could have had either early, past or treated syphilis infec-
tion. However, given the epidemiology of yaws and syphilis
in Ghana [1, 8–10], it is more likely that most of these
samples were from individuals who were previously ex-
posed to yaws rather than syphilis. It is worth noting that,
whatever the true classification of these past or treated
treponemal infections may be (i.e. whether past or
treated syphilis or yaws), they are not known to be
associated with adverse pregnancy outcomes [12, 15].
Our suspicion that most past treponemal infections
(RPR−/TPHA+) were more likely to have been due to pre-
vious exposure to yaws rather than syphilis is strength-
ened by the following ecological observations:
i. The pattern of regional distribution of yaws seems to
reflect regional HSS syphilis seropositivity in most
instances, suggesting that treponemal test
seropositivity may be due to previous exposure to
yaws, since clinically recognisable syphilis has been
relatively rare in Ghana.
ii. In the younger age groups of 15–19 years treponemal
tests seroprevalence generally far exceeds that of HIV
(since 2004) suggesting a non-venereal treponemal
infection rather than syphilis. This is consistent with
ongoing and not too distant yaws transmission in
these communities [14]. It is unlikely that these
adolescents acquired syphilis congenitally, as they
would not have survived without any treatment.
Generally, in settings of high treponemal infections
(including yaws), treponemal tests alone tend to over-
estimate the seroprevalence of active syphilis infection,
and are best used in conjunction with non-treponemal
tests [3, 6, 16]. In fact, WHO recommends the use of a
non-treponemal test for screening in such high preva-
lence settings [6]. Where treponemal tests are used for
screening, it is recommended that seropositive samples
should be subsequently tested with quantitative non-
treponemal tests to determine infection status (past or
active infection) [3, 16]. The findings of this study not-
withstanding, it must be emphasized that pregnant
women who test positive for syphilis using treponemal
point-of-care tests during antenatal care must be treated
on the same visit rather requesting further testing with
Table 3 Summary of 2007 HIV Sentinel Survey (HSS) syphilis test results and results of samples selected for retesting
Categories of HSS results DS+/TPHA+ DS−/TPHA0 DS+/TPHA− DS+/TPHA0 aDS0/TPHA+ Total
Number of all HSS samples 1,097 17,041 135 62 31 18,366
Number of selected samples 1,001 1,118 59 36 0 2,214
Number of RPR+/TPHA+ cases 158 42 0 3 0 203
Estimated number of active syphilis cases 173.15 640.18 0 5.17 NS 818.50
DS Determine syphilis TP, TPHA Treponema pallidum haemagglutination assay, RPR Rapid plasma reagin, TPHA0 − TPHA result not available, DS0 DS result not
available, NS samples not selected for retesting, aDS0/TPHA+ samples (n = 31) were excluded from the final analysis. Therefore, denominator for the overall
estimate was (18,366–31) =18,335
Note: Only DS+/TPHA+ samples were regarded as “syphilis” seropositive samples (more accurately, treponemal seropositives) during the sentinel survey; all other
samples were considered to be negative
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non-treponemal tests to avoid delays and missed oppor-
tunities: the benefits of early treatment far outweigh the
risks of overtreatment (which are rather rare) [3, 16].
The study had some limitations. First, because of the
matching system used in selection, negative samples
from sites with high HSS syphilis positivity rates were
more likely to be selected, and indeed samples from one
site out of 40 which did not have positive samples ended
up not being included. Second, the true syphilis infection
status of 21 RPR+/TPHA- samples could not be deter-
mined because we could not use a tie-breaker test such
as the FTA-ABS. However, the overall adjusted preva-
lence of active syphilis was unlikely to be affected due to
the relatively small number of such samples (0.9% of
total). Third, 96 (8.8%) of HSS syphilis positive samples
were not available for retesting, leading to slight inaccur-
acy of results. It is possible that some samples were used
up during the HSS testing. Fourth, repeated freeze-thaw
cycles may have affected the sensitivity of our results.
However, the loss in sensitivity is expected to be mar-
ginal as the necessary precautions were taken to minim-
ise the number of freeze-thaw cycles.
Conclusion
The nationally adopted HSS syphilis testing strategy of
using two sequential treponemal tests for convenience rea-
sons is particularly not suited for detecting active syphilis
infection in Ghana, thereby undermining its informative
purpose. There is an urgent need to review the strategy for
syphilis surveillance to obtain accurate data that are neces-
sary to inform policy and track impact of interventions.
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